The proposal covers assay, dissolution, impurities and sterility failures; September’s regulatory alert lists 330 medicines that did not meet prescribed. The Union ministry of health and family welfare has proposed immediately suspending licences of those drug manufacturers whose products were classified as “not of standard quality” (NSQ) after. Drugs Rules, 1945, seek to enable immediate suspension of manufacturing licences following critical quality failures, with reinstatement conditional on corrective action and regulatory.